Cell-mediated immune response and cross-protective efficacy of binary ethylenimine-inactivated bluetongue virus serotype-1 vaccine in sheep

Vaccine

Volumn 28, Issue 13, 2010, Pages 2522-2531

  Umeshappa, Channakeshava Sokke ^a   Singh, Karam Pal ^a   Pandey, Awadh Bihari ^a   Singh, Rabindra Prasad ^a   Nanjundappa, Roopa Hebbandi ^b  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^b KUVEMPU UNIVERSITY   (India)

Author keywords

Binary ethylenimine inactivated saponin adjuvanted BTV 1 vaccine; Cellular and cytokine response; Cross protection

Indexed keywords

ALPHA INTERFERON; BINARY ETHYLENIMINE INACTIVATED SAPONIN BTV 1 VACCINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLUETONGUE ORBIVIRUS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; INFECTION PREVENTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROTYPE; SHEEP; VIRUS INFECTION; VIRUS LOAD;

ANIMALS; AZIRIDINES; BLUETONGUE; BLUETONGUE VIRUS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CROSS PROTECTION; CYTOTOXICITY, IMMUNOLOGIC; DISINFECTANTS; INDIA; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-2; SEVERITY OF ILLNESS INDEX; SHEEP; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 77649186390     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.01.039     Document Type: Article

References (57)

1. Maclachlan N.J., Drew C.P., Darpel K.E., and Worwa G. The pathology and pathogenesis of bluetongue. J Comp Pathol 141 1 (2009) 1-16
2. Maan S., Maan N.S., Samuel A.R., Rao S., Attoui H., and Mertens P.P. Analysis and phylogenetic comparisons of full-length VP2 genes of the 24 bluetongue virus serotypes. J Gen Virol 88 Pt 2 (2007) 621-630
3. Bhanuprakash V., Indrani B.K., Hosamani M., Balamurugan V., and Singh R.K. Bluetongue vaccines: the past, present and future. Expert Rev Vaccines 8 2 (2009) 191-204
4. Ramakrishnan M.A., Singh K.P., Pandey A.B., Singh R., Nandi S., and Mehrotra M.L. Genomic diversity of Indian isolates of bluetongue virus. Acta Virol 49 4 (2005) 285-286
5. Dahiya S., Prasad G., and Kovi R.C. VP2 gene based phylogenetic relationship of Indian isolates of Bluetongue virus serotype 1 and other serotypes from different parts of the world. DNA Seq 15 5-6 (2004) 351-361
6. MacLachlan N.J., and Osburn B.I. Impact of bluetongue virus infection on the international movement and trade of ruminants. J Am Vet Med Assoc 228 9 (2006) 1346-1349
7. Mellor P.S., Baylis M., and Mertens P.P. Bluetongue: biology of animal infections. first ed. (2009), Academic Press, USA
8. Prasad G. Whither bluetongue research in India. Indian J Microbiol 40 (2000) 163-175
9. Saegerman C., Berkvens D., and Mellor P.S. Bluetongue epidemiology in the European Union. Emerg Infect Dis 14 4 (2008) 539-544
10. Eschbaumer M., Hoffmann B., Konig P., Teifke J.P., Gethmann J.M., Conraths F.J., et al. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep. Vaccine 27 31 (2009) 4169-4175
11. Jeggo M.H., Wardley R.C., and Brownlie J. A study of the role of cell-mediated immunity in bluetongue virus infection in sheep, using cellular adoptive transfer techniques. Immunology 52 3 (1984) 403-410
12. Andrew M., Whiteley P., Janardhana V., Lobato Z., Gould A., and Coupar B. Antigen specificity of the ovine cytotoxic T lymphocyte response to bluetongue virus. Vet Immunol Immunopathol 47 3-4 (1995) 311-322
13. Janardhana V., Andrew M.E., Lobato Z.I., and Coupar B.E. The ovine cytotoxic T lymphocyte responses to bluetongue virus. Res Vet Sci 67 3 (1999) 213-221
14. Jeggo M.H., and Wardley R.C. Generation of cross-reactive cytotoxic T lymphocytes following immunization of mice with various bluetongue virus types. Immunology 45 4 (1982) 629-635
15. Jones L.D., Chuma T., Hails R., Williams T., and Roy P. The non-structural proteins of bluetongue virus are a dominant source of cytotoxic T cell peptide determinants. J Gen Virol 77 Pt 5 (1996) 997-1003
16. Jones L.D., Williams T., Bishop D., and Roy P. Baculovirus-expressed nonstructural protein NS2 of bluetongue virus induces a cytotoxic T-cell response in mice which affords partial protection. Clin Diagn Lab Immunol 4 3 (1997) 297-301
17. Lobato Z.I., Coupar B.E., Gray C.P., Lunt R., and Andrew M.E. Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens. Vet Immunol Immunopathol 59 3-4 (1997) 293-309
18. Wade-Evans A.M., Romero C.H., Mellor P., Takamatsu H., Anderson J., Thevasagayam J., et al. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge. Virology 220 1 (1996) 227-231
19. Hemati B., Contreras V., Urien C., Bonneau M., Takamatsu H.H., Mertens P.P., et al. Bluetongue virus targets conventional dendritic cells in skin lymph. J Virol 83 17 (2009) 8789-8799
20. Hamers C., Rehbein S., Hudelet P., Blanchet M., Lapostolle B., Cariou C., et al. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep. Vaccine 27 21 (2009) 2789-2793
21. Noad R., and Roy P. Bluetongue vaccines. Vaccine 27 Suppl 4 (2009) D86-D89
22. Savini G., Hamers C., Conte A., Migliaccio P., Bonfini B., Teodori L., et al. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle. Vet Microbiol 133 1-2 (2009) 1-8
23. Savini G., MacLachlan N.J., Sanchez-Vizcaino J.M., and Zientara S. Vaccines against bluetongue in Europe. Comp Immunol Microbiol Infect Dis 31 2-3 (2008) 101-120
24. Brown L.E., and Kelso A. Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes. Immunol Cell Biol 87 4 (2009) 300-308
25. Deliyannis G., Jackson D.C., Dyer W., Bates J., Coulter A., Harling-McNabb L., et al. Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use. Vaccine 16 20 (1998) 2058-2068
26. Sabarth N., Howard M.K., Savidis-Dacho H., van Maurik A., Barrett P.N., and Kistner O. Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model. Vaccine 28 3 (2010) 650-656
27. Schwartz-Cornil I., Mertens P.P., Contreras V., Hemati B., Pascale F., Breard E., et al. Bluetongue virus: virology, pathogenesis and immunity. Vet Res 39 5 (2008) 46
28. Stott J.L., Barber T.L., and Osburn B.I. Immunologic response of sheep to inactivated and virulent bluetongue virus. Am J Vet Res 46 5 (1985) 1043-1049
29. Stevens D.R., Stott J., Osburn B.I., Giles R., Wiesehahn G.P., and Barber T.L. Potency and efficacy of inactivated bluetongue virus vaccines. Prog Clin Biol Res 178 (1985) 649-652
30. Stott J.V., Osburn B.I., Barbar T.L., and Sawyer M. Immunological responses of sheep to an experimental inactivated vaccine. J Am Vet Med Assoc 175 (1979) 611
31. Ramakrishnan M.A., Pandey A.B., Singh K.P., Singh R., Nandi S., and Mehrotra M.L. Immune responses and protective efficacy of binary ethylenimine (BEI)-inactivated bluetongue virus vaccines in sheep. Vet Res Commun 30 8 (2006) 873-880
32. Culling C.F.A. Handbook of histopathological technique London (1957), Butterworth and Co. Ltd
33. Huismans H., van der Walt N.T., Cloete M., and Erasmus B.J. Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep. Virology 157 1 (1987) 172-179
34. Ellis J.A., Luedke A.J., Davis W.C., Wechsler S.J., Mecham J.O., Pratt D.L., et al. T lymphocyte subset alterations following bluetongue virus infection in sheep and cattle. Vet Immunol Immunopathol 24 1 (1990) 49-67
35. Pernthaner A., Cole S.A., Morrison L., and Hein W.R. Increased expression of interleukin-5 (IL-5), IL-13, and tumor necrosis factor alpha genes in intestinal lymph cells of sheep selected for enhanced resistance to nematodes during infection with Trichostrongylus colubriformis. Infect Immun 73 4 (2005) 2175-2183
36. Giulietti A., Overbergh L., Valckx D., Decallonne B., Bouillon R., and Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25 4 (2001) 386-401
37. Bhagat J., Ahmed K.A., Tyagi P., Saxena M., and Saxena V.K. Effects of supplemental chromium on interferon-gamma (IFN-gamma) mRNA expression in response to Newcastle disease vaccine in broiler chicken. Res Vet Sci (2007)
38. Attoui H., Billoir F., Cantaloube J.F., Biagini P., de Micco P., and de Lamballerie X. Strategies for the sequence determination of viral dsRNA genomes. J Virol Methods 89 1-2 (2000) 147-158
39. Takamatsu H., and Jeggo M.H. Cultivation of bluetongue virus-specific ovine T cells and their cross-reactivity with different serotype viruses. Immunology 66 2 (1989) 258-263
40. Lacetera N., and Ronchi B. Evaluation of antibody response and nonspecific lymphocyte blastogenesis following inoculation of a live attenuated bluetongue virus vaccine in goats. Am J Vet Res 65 10 (2004) 1331-1334
41. Hammoumi S., Breard E., Sailleau C., Russo P., Grillet C., Cetre-Sossah C., et al. Studies on the safety and immunogenicity of the South African bluetongue virus serotype 2 monovalent vaccine: specific detection of the vaccine strain genome by RT-PCR. J Vet Med B Infect Dis Vet Public Health 50 7 (2003) 316-321
42. Malek T.R. T helper cells, IL-2 and the generation of cytotoxic T-cell responses. Trends Immunol 23 10 (2002) 465-467
43. Schoenborn J.R., and Wilson C.B. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96 (2007) 41-101
44. Mescher M.F., Curtsinger J.M., Agarwal P., Casey K.A., Gerner M., Hammerbeck C.D., et al. Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev 211 (2006) 81-92
45. Goriely S., Neurath M.F., and Goldman M. How microorganisms tip the balance between interleukin-12 family members. Nat Rev Immunol 8 1 (2008) 81-86
46. Szabo G., and Dolganiuc A. The role of plasmacytoid dendritic cell-derived IFN alpha in antiviral immunity. Crit Rev Immunol 28 1 (2008) 61-94
47. Kensil C.R. Saponins as vaccine adjuvants. Crit Rev Ther Drug Carrier Syst 13 1-2 (1996) 1-55
48. Sun H.X., Xie Y., and Ye Y.P. Advances in saponin-based adjuvants. Vaccine 27 12 (2009) 1787-1796
49. Whetter L.E., Maclachlan N.J., Gebhard D.H., Heidner H.W., and Moore P.F. Bluetongue virus infection of bovine monocytes. J Gen Virol 70 Pt 7 (1989) 1663-1676
50. Brodie S.J., Wilson W.C., O'Hearn P.M., Muthui D., Diem K., and Pearson L.D. The effects of pharmacological and lentivirus-induced immune suppression on orbivirus pathogenesis: assessment of virus burden in blood monocytes and tissues by reverse transcription-in situ PCR. J Virol 72 7 (1998) 5599-5609
51. Jeggo M.H., Wardley R.C., and Brownlie J. Importance of ovine cytotoxic T cells in protection against bluetongue virus infection. Prog Clin Biol Res 178 (1985) 477-487
52. Takamatsu H., Burroughs J.N., Wade-Evans A.M., and Mertens P.P. Identification of a bluetongue virus serotype 1-specific ovine helper T-cell determinant in outer capsid protein VP2. Virology 177 1 (1990) 396-400
53. Kees U., and Krammer P.H. Most influenza A virus-specific memory cytotoxic T lymphocytes react with antigenic epitopes associated with internal virus determinants. J Exp Med 159 2 (1984) 365-377
54. Yewdell J.W., Bennink J.R., Smith G.L., and Moss B. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci U S A 82 6 (1985) 1785-1789
55. Perrin A., Albina E., Breard E., Sailleau C., Prome S., Grillet C., et al. Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants. Vaccine 25 37-38 (2007) 6774-6783
56. Singh K.P., Maan S., Samuel A.R., Rao S., Meyer A.J., and Mertens P.P.C. Phylogenetic analysis of bluetongue virus genome segment 6 (encoding VP5) from different serotypes. Vet Ital 40 4 (2004) 479-483
57. Yamakawa M., Krasnyck V., and Roy P. Phylogenetic relationships of the VP2 protein of a virulent isolate of bluetongue virus (BTV-23) compared to those of 6 other BTV serotypes. Virus Res 34 1 (1994) 81-92